Approval · Notice of Compliance 1610 · 1999
MIDAZOLAM: Notice of Compliance 1610
Issued June 21, 1999
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1610
- Date
- June 21, 1999
- Company
- Sabex Inc.Boucherville, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Therapeutic class
- Premedicant - sedative - anaesthetic agent
- Canadian reference product
- VERSED (Hoffmann-La Roche Limited)